Global Contrast-Enhanced Digital Mammography (CEDM) Market Overview:
Global Contrast-Enhanced Digital Mammography (CEDM) Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Contrast-Enhanced Digital Mammography (CEDM) Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Contrast-Enhanced Digital Mammography (CEDM) involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Contrast-Enhanced Digital Mammography (CEDM) Market:
The Contrast-Enhanced Digital Mammography (CEDM) Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Contrast-Enhanced Digital Mammography (CEDM) Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Contrast-Enhanced Digital Mammography (CEDM) Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Contrast-Enhanced Digital Mammography (CEDM) market has been segmented into:
Vasoactive intestinal peptide receptor agonists
Somatostatin Analogs
Renin-angiotensin-aldosterone system inhibitors
Diuretics
Pain medications
By Application, Contrast-Enhanced Digital Mammography (CEDM) market has been segmented into:
Screen-Film Contrast-Enhanced Digital Mammography
Digital Contrast Enhanced Mammography
Tomosynthesis Contrast-Enhanced Digital Mammography
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Contrast-Enhanced Digital Mammography (CEDM) market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Contrast-Enhanced Digital Mammography (CEDM) market.
Top Key Players Covered in Contrast-Enhanced Digital Mammography (CEDM) market are:
Toshiba Medical Systems
Carestream Health
Canon Medical Systems
Hologic
Ziehm Imaging
Samsung Electronics
Philips Healthcare
Fujifilm Holdings
Siemens Healthineers
GE Healthcare
Shimadzu
Konica Minolta
Hitachi Medical Systems
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Contrast-Enhanced Digital Mammography (CEDM) Market Type
4.1 Contrast-Enhanced Digital Mammography (CEDM) Market Snapshot and Growth Engine
4.2 Contrast-Enhanced Digital Mammography (CEDM) Market Overview
4.3 Vasoactive intestinal peptide receptor agonists
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Vasoactive intestinal peptide receptor agonists: Geographic Segmentation Analysis
4.4 Somatostatin Analogs
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Somatostatin Analogs: Geographic Segmentation Analysis
4.5 Renin-angiotensin-aldosterone system inhibitors
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Renin-angiotensin-aldosterone system inhibitors: Geographic Segmentation Analysis
4.6 Diuretics
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.6.3 Diuretics: Geographic Segmentation Analysis
4.7 Pain medications
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.7.3 Pain medications: Geographic Segmentation Analysis
Chapter 5: Contrast-Enhanced Digital Mammography (CEDM) Market Application
5.1 Contrast-Enhanced Digital Mammography (CEDM) Market Snapshot and Growth Engine
5.2 Contrast-Enhanced Digital Mammography (CEDM) Market Overview
5.3 Screen-Film Contrast-Enhanced Digital Mammography
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Screen-Film Contrast-Enhanced Digital Mammography: Geographic Segmentation Analysis
5.4 Digital Contrast Enhanced Mammography
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Digital Contrast Enhanced Mammography: Geographic Segmentation Analysis
5.5 Tomosynthesis Contrast-Enhanced Digital Mammography
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Tomosynthesis Contrast-Enhanced Digital Mammography: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Contrast-Enhanced Digital Mammography (CEDM) Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 TOSHIBA MEDICAL SYSTEMS
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 CARESTREAM HEALTH
6.4 CANON MEDICAL SYSTEMS
6.5 HOLOGIC
6.6 ZIEHM IMAGING
6.7 SAMSUNG ELECTRONICS
6.8 PHILIPS HEALTHCARE
6.9 FUJIFILM HOLDINGS
6.10 SIEMENS HEALTHINEERS
6.11 GE HEALTHCARE
6.12 SHIMADZU
6.13 KONICA MINOLTA
6.14 HITACHI MEDICAL SYSTEMS
Chapter 7: Global Contrast-Enhanced Digital Mammography (CEDM) Market By Region
7.1 Overview
7.2. North America Contrast-Enhanced Digital Mammography (CEDM) Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Vasoactive intestinal peptide receptor agonists
7.2.2.2 Somatostatin Analogs
7.2.2.3 Renin-angiotensin-aldosterone system inhibitors
7.2.2.4 Diuretics
7.2.2.5 Pain medications
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Screen-Film Contrast-Enhanced Digital Mammography
7.2.3.2 Digital Contrast Enhanced Mammography
7.2.3.3 Tomosynthesis Contrast-Enhanced Digital Mammography
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Contrast-Enhanced Digital Mammography (CEDM) Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Vasoactive intestinal peptide receptor agonists
7.3.2.2 Somatostatin Analogs
7.3.2.3 Renin-angiotensin-aldosterone system inhibitors
7.3.2.4 Diuretics
7.3.2.5 Pain medications
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Screen-Film Contrast-Enhanced Digital Mammography
7.3.3.2 Digital Contrast Enhanced Mammography
7.3.3.3 Tomosynthesis Contrast-Enhanced Digital Mammography
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Contrast-Enhanced Digital Mammography (CEDM) Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Vasoactive intestinal peptide receptor agonists
7.4.2.2 Somatostatin Analogs
7.4.2.3 Renin-angiotensin-aldosterone system inhibitors
7.4.2.4 Diuretics
7.4.2.5 Pain medications
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Screen-Film Contrast-Enhanced Digital Mammography
7.4.3.2 Digital Contrast Enhanced Mammography
7.4.3.3 Tomosynthesis Contrast-Enhanced Digital Mammography
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Contrast-Enhanced Digital Mammography (CEDM) Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Vasoactive intestinal peptide receptor agonists
7.5.2.2 Somatostatin Analogs
7.5.2.3 Renin-angiotensin-aldosterone system inhibitors
7.5.2.4 Diuretics
7.5.2.5 Pain medications
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Screen-Film Contrast-Enhanced Digital Mammography
7.5.3.2 Digital Contrast Enhanced Mammography
7.5.3.3 Tomosynthesis Contrast-Enhanced Digital Mammography
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Contrast-Enhanced Digital Mammography (CEDM) Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Vasoactive intestinal peptide receptor agonists
7.6.2.2 Somatostatin Analogs
7.6.2.3 Renin-angiotensin-aldosterone system inhibitors
7.6.2.4 Diuretics
7.6.2.5 Pain medications
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Screen-Film Contrast-Enhanced Digital Mammography
7.6.3.2 Digital Contrast Enhanced Mammography
7.6.3.3 Tomosynthesis Contrast-Enhanced Digital Mammography
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Contrast-Enhanced Digital Mammography (CEDM) Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Vasoactive intestinal peptide receptor agonists
7.7.2.2 Somatostatin Analogs
7.7.2.3 Renin-angiotensin-aldosterone system inhibitors
7.7.2.4 Diuretics
7.7.2.5 Pain medications
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Screen-Film Contrast-Enhanced Digital Mammography
7.7.3.2 Digital Contrast Enhanced Mammography
7.7.3.3 Tomosynthesis Contrast-Enhanced Digital Mammography
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Contrast-Enhanced Digital Mammography (CEDM) Scope:
|
Report Data
|
Contrast-Enhanced Digital Mammography (CEDM) Market
|
|
Contrast-Enhanced Digital Mammography (CEDM) Market Size in 2025
|
USD XX million
|
|
Contrast-Enhanced Digital Mammography (CEDM) CAGR 2025 - 2032
|
XX%
|
|
Contrast-Enhanced Digital Mammography (CEDM) Base Year
|
2024
|
|
Contrast-Enhanced Digital Mammography (CEDM) Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Toshiba Medical Systems, Carestream Health, Canon Medical Systems, Hologic, Ziehm Imaging, Samsung Electronics, Philips Healthcare, Fujifilm Holdings, Siemens Healthineers, GE Healthcare, Shimadzu, Konica Minolta, Hitachi Medical Systems.
|
|
Key Segments
|
By Type
Vasoactive intestinal peptide receptor agonists
Somatostatin Analogs
Renin-angiotensin-aldosterone system inhibitors
Diuretics
Pain medications
By Applications
Screen-Film Contrast-Enhanced Digital Mammography
Digital Contrast Enhanced Mammography
Tomosynthesis Contrast-Enhanced Digital Mammography
|
